18 results on '"Bowker, Karen"'
Search Results
2. Limited phylogenetic overlap between fluoroquinolone-resistant Escherichia coli isolated on dairy farms and those causing bacteriuria in humans living in the same geographical region
3. Comment on: Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections
4. Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
5. Antibacterial effect of imipenem/relebactam on aerobic Gram-negative bacilli: in vitro simulations of 7 or 14 day human exposures
6. Antibacterial effect of ceftolozane/tazobactam in combination with amikacin against aerobic Gram-negative bacilli studied in an in vitro pharmacokinetic model of infection
7. Pharmacodynamics of inhaled amikacin (BAY 41-6551) studied in an in vitro pharmacokinetic model of infection
8. The pharmacodynamics of avibactam in combination with ceftaroline or ceftazidime againstβ-lactamase-producing Enterobacteriaceae studied in anin vitromodel of infection
9. Differences in the pharmacodynamics of ceftaroline against different species of Enterobacteriaceae studied in anin vitropharmacokinetic model of infection
10. Prevalence of antibiotic resistance in Escherichia coli isolated from urine samples routinely referred by general practitioners in a large urban centre in south-west England
11. Comparative antibacterial effects of daptomycin, vancomycin and teicoplanin studied in an in vitro pharmacokinetic model of infection
12. Discrepancy between viable counts and light output as viability measurements, following ciprofloxacin challenge of self-bioluminescent Pseudomonas aeruginosa biofilms
13. In Vitro Models, In Vivo Models, and Pharmacokinetics: What Can We Learn from In Vitro Models?
14. Use of meropenem 3 g once daily for outpatient treatment of infective exacerbations of bronchiectasis
15. Exploration of the in-vitro pharmacodynamic activity of moxifloxacin for Staphylococcus aureus and streptococci of Lancefield Groups A and G
16. Use of a clinical Escherichia coli isolate expressing lux genes to study the antimicrobial pharmacodynamics of moxifloxacin
17. Bactericidal activity, post antibiotic effect and modified controlled effective regrowth time of meropenem at high concentrations
18. Synergy testing of macrolide combinations using the chequerboard technique
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.